Drugs / levomefolate calcium

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) BEYAZ 2010-09-24 fda.gov

Trials 3 · a red edge is where a trial was stopped

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT01258660 Dec 2006 → Jan 2008 Bayer Completed No outcome recorded
Phase 31 trial
Phase 3 NCT01902264 Aug 2013 → Feb 2015 Bayer Completed No outcome recorded
Phase not applicable1 trial
NCT00348933 Jul 2006 → Feb 2010 Angelman syndrome University of California, San Diego Completed No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT01360996 Background Aug 2011 → Feb 2015 polycystic ovary syndrome Woman's Completed No outcome recorded

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

FieldValueCited text
Known as levomefolate calcium “1 pill daily-24 days of drospirenone 3 mg (3 mg DRSP)/ethinyl estradiol 20 μg (20 μg EE)/levomefolate calcium 0.451 mg (folate) -followed by 4 days of levomefolate calcium...” NCT01360996
1

levomefolate calcium (Metafolin, a registered vitamin supplement)” NCT01258660

Known as folate “1 pill daily-24 days of drospirenone 3 mg (3 mg DRSP)/ethinyl estradiol 20 μg (20 μg EE)/levomefolate calcium 0.451 mg (folate) -followed by 4 days of levomefolate calcium...” NCT01360996
Known as Levomefolate “Study of Treatment With the Combination of Drospirenone Plus Ethinyl Estradiol Plus Levomefolate Calcium in Mexican Women Seeking Contraception” NCT01902264
Known as Metafolin “levomefolate calcium (Metafolin, a registered vitamin supplement)” NCT01258660
1

NCT00348933

Route Oral “Folate-boosted 3 mg DRSP/20 μg EE-24/4 oral contraceptive” NCT01360996